Status of current trials and potential future trials with sparsentan
Expert Opin Emerg Drugs. 2023 Jul 19. doi: 10.1080/14728214.2023.2239151. Online ahead of print.NO ABSTRACTPMID:37466432 | DOI:10.1080/14728214.2023.2239151 (Source: Expert Opinion on Emerging Drugs)
Source: Expert Opinion on Emerging Drugs - July 19, 2023 Category: Drugs & Pharmacology Authors: Howard Trachtman Radko Komers Jula Inrig Source Type: research
Emerging peptide therapeutics for the treatment of ovarian cancer
Expert Opin Emerg Drugs. 2023 Dec;28(2):129-144. doi: 10.1080/14728214.2023.2218643. Epub 2023 Jun 7.ABSTRACTINTRODUCTION: The discovery of therapeutic proteomic targets has resulted in remarkable advances in oncology. Identification of functional and hallmark peptides in ovarian cancer can be leveraged for diagnostic and therapeutic targeting. These targets are expressed in different tumor cell locations, making them excellent candidates for theranostic imaging, precision therapeutics, and immunotherapy. The ideal target is homogeneously overexpressed in malignant cells with no expression in healthy cells, thereby avoidin...
Source: Expert Opinion on Emerging Drugs - June 7, 2023 Category: Drugs & Pharmacology Authors: Ana C Veneziani Eduardo Gonzalez-Ochoa Amit M Oza Source Type: research
